- |||||||||| birinapant (IGM-9427) / IGM Biosciences
Trial completion, Enrollment change, Combination therapy: Birinapant With 5-azacitidine in MDS Subjects Who Are Na (clinicaltrials.gov) - Apr 21, 2016 P1/2, N=21, Completed, Recruiting --> Completed | N=40 --> 2 | Trial primary completion date: Nov 2017 --> Mar 2016 Active, not recruiting --> Completed | N=45 --> 21
- |||||||||| Trial completion: TevaGastrim for Stem Cell Mobilization Sibling Donors (clinicaltrials.gov) - Apr 20, 2016
P2, N=24, Completed, Completed --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Dec 2016 Active, not recruiting --> Completed
- |||||||||| pracinostat (SB939) / Helsinn, MEI, Menarini
Enrollment closed, Trial primary completion date, Combination therapy: Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome (clinicaltrials.gov) - Apr 18, 2016 P2, N=102, Active, not recruiting, Completed --> Active, not recruiting Completed --> Active, not recruiting | Trial primary completion date: May 2015 --> Mar 2017
- |||||||||| Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Enrollment closed, Enrollment change, Post-transplantation: Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT (clinicaltrials.gov) - Apr 13, 2016 P2, N=200, Active, not recruiting, Trial primary completion date: Aug 2017 --> Apr 2016 Recruiting --> Active, not recruiting | N=60 --> 200
- |||||||||| Tasigna (nilotinib) / Novartis, Inhibikase
Trial completion, Enrollment change: Telemonitoring Study - for Chronic Myeloid Leukemia (CML) (clinicaltrials.gov) - Apr 8, 2016 P=N/A, N=14, Completed, No longer recruiting --> Completed Active, not recruiting --> Completed | N=48 --> 14
- |||||||||| Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Enrollment closed, Enrollment change, Trial primary completion date: Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies (clinicaltrials.gov) - Mar 29, 2016 P2, N=9, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=46 --> 9 | Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| volasertib (NBL-001) / Oncoheroes, Notable Labs
Trial initiation date, Trial primary completion date: VIAC: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia (clinicaltrials.gov) - Mar 25, 2016 P1, N=30, Not yet recruiting, Recruiting --> Active, not recruiting | N=46 --> 9 | Trial primary completion date: Dec 2015 --> Dec 2016 Initiation date: Sep 2015 --> Jun 2016 | Trial primary completion date: Aug 2017 --> Dec 2017
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder (clinicaltrials.gov) - Mar 21, 2016
P=N/A, N=15, Terminated, Completed --> Terminated; The study was terminated due to low enrollment. N=60 --> 15 | Withdrawn --> Terminated | Trial primary completion date: Mar 2010 --> Feb 2009; This study was stopped due to poor enrollment numbers
- |||||||||| PLX51107 / Daiichi Sankyo
Enrollment open, Metastases: A Study of PLX51107 in Advanced Malignancies (clinicaltrials.gov) - Mar 17, 2016 P1, N=60, Recruiting, N=60 --> 15 | Withdrawn --> Terminated | Trial primary completion date: Mar 2010 --> Feb 2009; This study was stopped due to poor enrollment numbers Not yet recruiting --> Recruiting
- |||||||||| pracinostat (SB939) / Helsinn, MEI, Menarini
Trial completion, P2 data, Enrollment change, Trial primary completion date: Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA (clinicaltrials.gov) - Mar 16, 2016 P2, N=45, Completed, Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=76 --> 45 | Trial primary completion date: Aug 2015 --> May 2015
- |||||||||| dasatinib / Generic mfg.
Trial primary completion date: Korean Post-marketing Surveillance for Sprycel (clinicaltrials.gov) - Mar 9, 2016 P=N/A, N=600, Recruiting, Trial primary completion date: Feb 2016 --> Jul 2017 Trial primary completion date: Dec 2016 --> May 2016
|